Glyscend's Grant - III Round

Glyscend raised a round of funding on November 17, 2016. Investors include Johnson & Johnson Innovation.

Glyscend is developing an approach to treating type 2 diabetes by recreating the effects of bariatric surgery, like gastric bypass, for diabetes and obesity without the need for invasive procedures.…

Articles about Glyscend's Grant - III Round: